Amneal Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Amneal Pharmaceuticals's estimated annual revenue is currently $2.1B per year.
- Amneal Pharmaceuticals's estimated revenue per employee is $386,194
- Amneal Pharmaceuticals's total funding is $854M.
Employee Data
- Amneal Pharmaceuticals has 5360 Employees.
- Amneal Pharmaceuticals grew their employee count by 8% last year.
Amneal Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Global Regulatory Affairs | Reveal Email/Phone |
2 | VP, R&D | Reveal Email/Phone |
3 | VP Transdermal Product Development | Reveal Email/Phone |
4 | SVP, US Quality | Reveal Email/Phone |
5 | SVP & CFO | Reveal Email/Phone |
6 | SVP, General Counsel | Reveal Email/Phone |
7 | VP Supply Chain | Reveal Email/Phone |
8 | VP, Specialty Sales & Marketing | Reveal Email/Phone |
9 | VP, Market Access and Trade | Reveal Email/Phone |
10 | QC Officer | Reveal Email/Phone |
Amneal Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Amneal Pharmaceuticals?
Privately owned and operated since 2001, Amneal is a growth-oriented company dedicated to developing and manufacturing the finest quality generic prescription drugs. We welcome you to tour our site and discover the many facets of our company.
keywords:N/A
$854M
Total Funding
5360
Number of Employees
$2.1B
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Amneal Pharmaceuticals News
Last week saw the US Food and Drug Administration (FDA) approve the Biologics License Application (BLA) from Amneal Pharmaceuticals Inc for...
"The entire Brand Institute and Drug Safety Institute Team congratulates Amneal Pharmaceuticals and mAbxience on the FDA approval of ALYMSYS,"...
Amneal Pharmaceuticals LLC. The case arose in an inter partes review (IPR) proceeding by challenger Amneal over Almirall's U.S. Patent No.
Other Companies in Bridgewater
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1313.3M | 6534 | 13% | N/A |
#2 | $2166.6M | 8632 | 5% | N/A |
#3 | $2600.4M | 10360 | 6% | N/A |
#4 | $38500M | 103675 | 2% | N/A |